Cite
HARVARD Citation
Wang, L. et al. (2016). An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer. Asia-Pacific journal of clinical oncology. 12 (4), pp. 380-387. [Online].